SJM
12
-31
VIX
46
13
SYF
69
-14
AME
62
-4
PM
49
-25
EIX
56
2
EQIX
59
6
KR
44
15
ED
45
3
RIG
37
-9
R
62
-14
NTAP
55
-3
CMG
56
6
KSS
52
-2
DE
46
-3
MDT
55
2
PWR
50
-20
HCA
62
2
AMT
30
-6
SE
41
-38
SJM
12
-31
VIX
46
13
SYF
69
-14
AME
62
-4
PM
49
-25
EIX
56
2
EQIX
59
6
KR
44
15
ED
45
3
RIG
37
-9
R
62
-14
NTAP
55
-3
CMG
56
6
KSS
52
-2
DE
46
-3
MDT
55
2
PWR
50
-20
HCA
62
2
AMT
30
-6
SE
41
-38
Financhill
Back

Parametric Equity Premium Income ETF Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Sell
46

PAPI
Parametric Equity Premium Income ETF

Last Price:
$26.25
Seasonality Move:
4.07%
Sell
23

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$32.84
Seasonality Move:
-0.96%
Sell
46
Parametric Equity Premium Income ETF (PAPI) is a Sell

Is Parametric Equity Premium Income ETF a Buy, Sell or Hold?

  • The current Parametric Equity Premium Income ETF [PAPI] share price is $26.20. The Score for PAPI is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • PAPI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.21. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PAPI Stock Price Chart

What is Parametric Equity Premium Income ETF's stock price today?

  • The Parametric Equity Premium Income ETF share price today is $26.20
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PAPI is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $33.21
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

PAPI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.09 Buy
Relative Strength Index (14 RSI): 57.01 Buy
Chaikin Money Flow: -4807 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.62 - 26.18) Buy
Bollinger Bands (100): (25.5 - 26.16) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.65 Buy
Relative Strength Index (14 RSI): 43.13 Sell
Chaikin Money Flow: -1062961 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.65 - 35.95) Sell
Bollinger Bands (100): (29.01 - 34.13) Buy

PAPI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.14 Buy
20-day SMA: 25.95 Buy
50-day SMA: 25.78 Buy
200-day SMA: 25.73 Buy
8-day EMA: 5.82 Buy
20-day EMA: 2.5 Buy
50-day EMA: 1.03 Buy
200-day EMA: 0.26 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.62 Sell
20-day SMA: 34.63 Sell
50-day SMA: 33.66 Sell
200-day SMA: 33.65 Sell
8-day EMA: 7.38 Buy
20-day EMA: 3.16 Buy
50-day EMA: 1.3 Buy
200-day EMA: 0.33 Buy

Parametric Equity Premium Income ETF Earnings Growth & PAPI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

Parametric Equity Premium Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):